scholarly journals Hyperthermia treatment planning for cervical cancer patients based on electrical conductivity tissue properties acquiredin vivowith EPT at 3 T MRI

2016 ◽  
Vol 32 (5) ◽  
pp. 558-568 ◽  
Author(s):  
Edmond Balidemaj ◽  
Henny Petra Kok ◽  
Gerben Schooneveldt ◽  
Astrid L.H.M.W. van Lier ◽  
Rob F. Remis ◽  
...  
Keyword(s):  
Electrical Conductivity ◽  
Cervical Cancer ◽  
Cancer Patients ◽  
Treatment Planning ◽  
Hyperthermia Treatment ◽  
Tissue Properties

scholarly journals Advantages of 3D-CT Based Conformal Radiotherapy Treatment Planning Over 2D Conventional Tera Six Planning for Cervical Cancer Treatment at Ocean Road Cancer Institute

2020 ◽  
Vol 8 (1) ◽  
pp. 59-68
Author(s):  
Khamis Amour ◽  
Dr. Khamza Maunda ◽  
Dr. Mohamed Mazunga ◽  
Dr. Peane Maleka ◽  
Professor Peter Msaki
Keyword(s):  
Cervical Cancer ◽  
At Risk ◽  
Radiation Therapy ◽  
Cancer Patients ◽  
Treatment Planning ◽  
Organs At Risk ◽  
Planning System ◽  
External Beam Radiation ◽  
Treatment Planning System ◽  
3D Ct

Although External Beam Radiation Therapy (EBRT) is essential tool for the radiation therapy of cervical cancer; only one cancer institute in Tanzania performs 3-Dimensional Conformal Radiation Therapy (3DCRT) Computed Tomography (CT)-based planning. To identify benefits and advantages of 3D-CRT over 2D- conventional radiation therapy (2D-CRT), dosimetric parameters for tumor targets and organs at risk (OARs) were compared between these modalities for 23 cervical cancer patients. 11 cervical cancer patients were CT scanned after proper positioning and immobilization and transferred to Eclipse Treatment Planning System (TPS) for dose planning. The remaining 12 curative intent patients were planned using 2D-CRT system and treatment times were calculated for each patient. From the CT based planning, the minimum dose (D min), maximum dose (D max) and mean dose (D mean) to Planning Target Volume (PTV) and organs at risk (OAR), were compared for each plan. On average, the optimized maximum doses for bladder, rectum, femoral heads, PTV and Gross Tumor Volume (GTV) were 46.56 Gy, 42.65 Gy, 28.76 Gy, 48.56 Gy and 48.53 Gy. For 2D-concentional planning, the dose rate was 75.75 cGy/min and the average treatment time was 1.6075 minutes. This study confirms that 3D CT-based planning is a good choice in the treatment protocol for carcinoma cervix as it delivered a highly homogeneous and conformal plan with superior dose coverage to PTV and better OARs sparing.

scholarly journals Role of Simulations in the Treatment Planning of Radiofrequency Hyperthermia Therapy in Clinics

2019 ◽  
Vol 2019 ◽  
pp. 1-12 ◽  
Author(s):  
Bibin Prasad ◽  
Jung Kyung Kim ◽  
Suzy Kim
Keyword(s):  
Treatment Planning ◽  
Human Anatomy ◽  
Clinical Aspects ◽  
Phase Array ◽  
Clinical Use ◽  
Hyperthermia Treatment ◽  
Tissue Properties ◽  
Hyperthermia Therapy ◽  
Radiofrequency Hyperthermia ◽  
Effective Development

Hyperthermia therapy is a treatment modality in which tumor temperatures are elevated to higher temperatures to cause damage to cancerous tissues. Numerical simulations are integral in the development of hyperthermia treatment systems and in clinical treatment planning. In this study, simulations in radiofrequency hyperthermia therapy are reviewed in terms of their technical development and clinical aspects for effective clinical use. This review offers an overview of mathematical models and the importance of tissue properties; locoregional mild hyperthermia therapy, including phantom and realistic human anatomy models; phase array systems; tissue damage; thermal dose analysis; and thermoradiotherapy planning. This review details the improvements in numerical approaches in treatment planning and their application for effective clinical use. Furthermore, the modeling of thermoradiotherapy planning, which can be integrated with radiotherapy to provide combined hyperthermia and radiotherapy treatment planning strategies, are also discussed. This review may contribute to the effective development of thermoradiotherapy planning in clinics.

Implementation of treatment planning in the routine clinical procedure of regional hyperthermia treatment of cervical cancer: An overview and the Rotterdam experience

2012 ◽  
Vol 28 (6) ◽  
pp. 570-581 ◽  
Author(s):  
Richard A. M. Canters ◽  
Margarethus M. Paulides ◽  
Martine F. Franckena ◽  
Jacoba van der Zee ◽  
Gerard C. van Rhoon
Keyword(s):  
Cervical Cancer ◽  
Treatment Planning ◽  
Hyperthermia Treatment ◽  
Regional Hyperthermia ◽  
Clinical Procedure

scholarly journals Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Travis T. Sims ◽  
Molly B. El Alam ◽  
Tatiana V. Karpinets ◽  
Stephanie Dorta-Estremera ◽  
Venkatesh L. Hegde ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Gut Microbiota ◽  
Cancer Patients ◽  
Gut Microbiome ◽  
Compositional Variation ◽  
Short Term ◽  
Microbiome Diversity ◽  
Term Survivor

AbstractDiversity of the gut microbiome is associated with higher response rates for cancer patients receiving immunotherapy but has not been investigated in patients receiving radiation therapy. Additionally, current studies investigating the gut microbiome and outcomes in cancer patients may not have adjusted for established risk factors. Here, we sought to determine if diversity and composition of the gut microbiome was independently associated with survival in cervical cancer patients receiving chemoradiation. Our study demonstrates that the diversity of gut microbiota is associated with a favorable response to chemoradiation. Additionally, compositional variation among patients correlated with short term and long-term survival. Short term survivor fecal samples were significantly enriched in Porphyromonas, Porphyromonadaceae, and Dialister, whereas long term survivor samples were significantly enriched in Escherichia Shigella, Enterobacteriaceae, and Enterobacteriales. Moreover, analysis of immune cells from cervical tumor brush samples by flow cytometry revealed that patients with a high microbiome diversity had increased tumor infiltration of CD4+ lymphocytes as well as activated subsets of CD4 cells expressing ki67+ and CD69+ over the course of radiation therapy. Modulation of the gut microbiota before chemoradiation might provide an alternative way to enhance treatment efficacy and improve treatment outcomes in cervical cancer patients.

Fas gene promoter –670 polymorphism in gynecological cancer

2006 ◽  
Vol 16 (Suppl 1) ◽  
pp. 179-182 ◽  
Author(s):  
M. Ueda ◽  
Y. Terai ◽  
K. Kanda ◽  
M. Kanemura ◽  
M. Takehara ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cervical Cancer ◽  
Cancer Patients ◽  
Germ Line ◽  
Gynecological Cancer ◽  
Gene Promoter ◽  
Single Nucleotide ◽  
Increased Risk ◽  
Significant Difference ◽  
Germ Line Polymorphism

Single-nucleotide polymorphism at −670 of Fas gene promoter (A/G) was examined in a total of 354 blood samples from normal healthy women and gynecological cancer patients. They consisted of 95 normal, 83 cervical, 108 endometrial, and 68 ovarian cancer cases. Eighty-three patients with cervical cancer had statistically higher frequency of GG genotype and G allele than 95 controls (P= 0.0353 and 0.0278, respectively). There was no significant difference in the genotype or allele prevalence between control subjects and endometrial or ovarian cancer patients. The Fas −670 GG genotype was associated with an increased risk for the development of cervical cancer (OR = 2.56, 95% CI = 1.08–6.10) compared with the AA genotype. The G allele also increased the risk of cervical cancer (OR = 1.60, 95% CI = 1.05–2.43) compared with the A allele. Germ-line polymorphism of Fas gene promoter −670 may be associated with the risk of cervical cancer in a Japanese population.

Sign in / Sign up

Export Citation Format

Share Document